Mycoril (Clotrimazole)

Clotrimazole, the active ingredient in Mycoril, blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for ergosterol synthesis. By preventing ergosterol formation, the drug disrupts the fungal cell membrane, increasing its permeability and leading to fungal cell death.

The dosing regimen for Mycoril is determined by the prescribing healthcare professional based on the infection type, severity, patient age and skin condition. Typically, a thin layer is applied to the affected area once or twice daily for the period recommended by the prescriber.

The safety of topical clotrimazole during pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mycoril.

To place an order, submit an enquiry on the Mycoril product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mycoril (clotrimazole) belongs to the imidazole class, offering broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, clotrimazole is generally well‑tolerated and available over the counter, though it may require longer treatment durations for some infections.

Mycoril should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Mycoril is applied topically to clean, dry skin. A thin layer should be spread over the affected area and surrounding skin, usually once or twice daily as directed by a healthcare professional. Hands should be washed after application.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, extensive contact dermatitis, blistering, or systemic effects from significant absorption. If any signs of a serious reaction appear, discontinue use and seek immediate medical attention.

Mycoril should not be used on broken, inflamed or infected skin, nor on mucous membranes, eyes, or genital areas. Individuals with known hypersensitivity to clotrimazole or any component of the formulation should avoid using the product.